Skip to main content
. 2024 Feb 15;16(1):3631. doi: 10.4102/phcfm.v16i1.3631

TABLE 5.

Healthcare provider’s practice related to diagnosis, crisis management and outpatient follow-up of sickle cell patients.

Variables Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Screening or diagnosis
Haemoglobin profile 52 44.1 54 49.1 9 90.0 54 67.5 169 53.1
Practitioner diagnosed at least one case of SCD 78 66.1 73 66.4 6 60.0 72 90.0 229 72.0
Symptoms or signs evoking diagnosis
Fever 60 50.8 63 57.3 4 40.0 49 61.3 176 55.3
Pain 89 75.4 83 75.5 6 60.0 76 95.0 254 79.9
Cutaneous-mucosal pallor 86 72.9 75 68.2 4 40.0 73 91.3 238 74.8
Notion of previous transfusion 82 69.5 78 70.9 5 50.0 74 92.5 239 75.2
Jaundice 87 73.7 75 68.2 6 60.0 62 77.5 230 72.3
Swelling of hands and feet in infants 69 58.5 63 57.3 4 40.0 65 81.3 201 63.2
Notion of multiple deaths in the immediate family 58 49.2 58 52.7 4 40.0 40 50.0 160 50.3
Assessment of pain
Subjective (based on patient complaint) 105 89.0 97 88.2 9 90.0 73 94.3 284 89.3
Using a scale 11 9.3 13 11.8 0 0.0 18 22.5 42 13.2
Use of usual analgesics
Empirically 62 52.5 63 57.3 5 50.0 42 52.5 172 54.1
According to WHO guidelines 56 47.5 59 53.6 5 50.0 44 55.0 164 51.6
Analgesics used
Paracetamol 57 48.3 40 36.4 5 50.0 22 27.5 124 39.0
Paracetamol and codéine 17 14.4 15 13.6 1 10.0 21 26.3 54 17.0
NSAIDs (diclofenac, ibuprofen…) 38 32.2 38 34.5 3 30.0 23 28.8 102 32.1
Tramadol 73 61.9 56 50.9 6 60.0 39 48.8 174 54.7
Morphine 1 0.8 0 0.0 0 0.0 0 0.0 1 0.3
Other treatments
Transfusion 9 7.6 14 12.7 1 10.0 12 15.0 36 11.3
Hydration with saline 12 10.2 15 13.6 2 20.0 14 17.5 43 13.5
Oxygen 35 29.7 35 31.8 4 40.0 39 48.8 113 35.5
Hydroxyurea 10 8.5 5 4.5 2 20.0 12 15.0 29 9.1
Outpatient follow-up
Provider has ever followed a SCD patient 40 33.9 38 34.5 5 50.0 32 40.0 115 36.2
SCD follow-up may be once a month 27 22.9 27 24.5 4 40.0 22 27.0 80 25.2
Laboratory tests
Haemoglobin. white blood cell count. complete blood count 103 87.3 97 88.2 8 80.0 71 88.8 279 87.7
Sedimentation rate 15 12.7 7 6.4 1 10.0 4 5.0 27 8.5
C-reactive protein 8 6.8 16 14.5 0 0.0 4 5.0 28 8.8
Lactate dehydrogenase 20 16.9 35 31.8 2 20.0 20 25.0 77 24.2
Urea and creatinine 38 32.2 19 17.3 2 20.0 53 66.3 112 35.2
Transaminases 24 20.3 34 30.9 4 40.0 41 51.3 103 32.4
Total/indirect bilirubin 38 32.2 26 23.6 4 40.0 52 65.3 120 37.7
10-reagent urine dipstick 19 16.1 44 40.0 2 20.0 21 26.3 86 27.0
Conventional radiography 37 31.4 61 55.5 4 40.0 38 47.5 140 44.0
Abdominal ultrasound 46 39.0 60 54.5 4 40.0 54 67.5 164 51.6
Cardiac ultrasound 47 39.8 30 27.3 4 40.0 45 56.3 126 39.6
Transcranial doppler ultrasound 24 20.3 46 41.8 4 40.0 29 36.3 103 32.4
Electrocardiogram 41 34.7 28 25.5 2 20.0 40 50.0 111 34.9
CT scan 34 28.8 21 19.1 1 10.0 25 33.8 81 25.5
Reason for transfer
Medical logistic and financial 80 67.5 72 65.5 7 70.0 48 60.0 207 65.1
Limited clinical skills of the centre 92 78.0 78 70.9 7 70.0 48 60.0 225 70.8
Medical reasons for referral
Pain resistant to usual analgesics 98 83.1 88 80.0 6 60.0 46 57.5 238 74.8
Persistent infection 101 85.6 100 90.9 5 50.0 53 66.3 259 81.4
Decompensated anaemia 97 82.2 92 83.6 8 80.0 67 83.8 264 83.0
Reference-counter-reference
Provider develops referral score 90 76.3 88 80.0 8 80.0 65 81.3 251 78.9
Provider receive counter-reference score 18 15.3 11 10.0 0 0.0 3 3.8 32 10.1

SCD, sickle cell disease; WHO, World Health Organizations; CT, computed tomography; NSAIDs, Non-steroidal anti-inflammatory drugs.